Pojen General Hospital · Taipei · District hospital

Prestige Class Health Checkup

US$685
NT$22,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call Pojen General Hospital on (02)25709966 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A premium-tier program with Brain MR angiography, Coronary artery calcium score, Low-dose chest CT, Abdominal ultrasound and Breast ultrasound and a 55-test panel.

English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Brain MR angiography

Aneurysms and narrowed brain arteries.

Coronary artery calcium score

Calcified plaque in heart arteries; refines heart attack risk.

Low-dose chest CT

Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Every test, in English

55 tests listed, 46 of them on our shared test list, so they line up against other hospitals' packages.

Vitals5
Blood Count2
Liver Function9
Kidney & Electrolytes2
Lipids & Cardiometabolic4
Glucose2
Tumor Markers5
Urine & Stool1
Cardiac2
X-ray1
Ultrasound6
CT Imaging2
MRI Imaging1
Eye3
ENT & Dental1
Show all 55 tests and what each screens for
TestScreens forAdd-on?
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.Incl.
Body composition analysisBody fat, muscle mass and water percentage.Incl.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.Incl.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.Incl.
Waist circumferenceCentral obesity, a marker of metabolic risk.Incl.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.Incl.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.Incl.
Liver Function
AlbuminLiver function and nutrition status.Incl.
Alkaline phosphataseLiver, bile duct and bone conditions.Incl.
ALT (SGPT)Liver cell damage; the most common liver screening test.Incl.
AST (SGOT)Liver cell damage.Incl.
Direct bilirubinBile duct obstruction.Incl.
Gamma-GTBile duct and alcohol-related liver stress.Incl.
Globulin and A/G ratioImmune protein levels.Incl.
Total bilirubinJaundice, liver and bile problems.Incl.
Total proteinNutrition and liver/kidney protein handling.Incl.
Kidney & Electrolytes
Estimated GFRKidney filtering capacity; stages chronic kidney disease.Incl.
Uric acidGout risk and kidney stone risk.Incl.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.Incl.
LDL cholesterolThe main cholesterol driving heart disease risk.Incl.
Total cholesterolCardiovascular risk.Incl.
TriglyceridesCardiovascular and pancreatitis risk.Incl.
Glucose
Fasting glucoseDiabetes and prediabetes.Incl.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.Incl.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).Incl.
CA-125Ovarian cancer marker.Incl.
CA 19-9Pancreatic and biliary cancer marker.Incl.
CEAColorectal and other GI cancer marker.Incl.
EBV VCA-IgANasopharyngeal cancer risk (common in Taiwan and southern China).Incl.
Urine & Stool
Stool occult blood (FIT)Colorectal cancer and polyps; the standard non-invasive colon screen.Incl.
Cardiac
Arterial stiffness (ABI / PWV)Peripheral artery disease and arterial stiffness.Incl.
Resting ECGHeart rhythm and signs of prior heart damage.Incl.
X-ray
Chest X-rayLung, heart size and chest abnormalities.Incl.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.Incl.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.Add-on
Carotid ultrasoundPlaque in the neck arteries; stroke risk.Incl.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).Add-on
Prostate ultrasoundProstate size and abnormalities.Add-on
Thyroid ultrasoundThyroid nodules.Add-on
CT Imaging
Coronary artery calcium scoreCalcified plaque in heart arteries; refines heart attack risk.Incl.
Low-dose chest CTEarly lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.Incl.
MRI Imaging
Brain MR angiographyAneurysms and narrowed brain arteries.Incl.
Eye
Color visionColor vision deficiency.Incl.
Intraocular pressureGlaucoma.Incl.
Visual acuityVision sharpness.Incl.
ENT & Dental
Hearing testHearing loss.Incl.
Vitals
Blood pressureIncl.
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisIncl.
Body fat, muscle mass and water percentage.
Height, weight and BMIIncl.
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Incl.
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceIncl.
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood countIncl.
Anemia, infection and blood cell disorders.
White blood cell differentialIncl.
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
AlbuminIncl.
Liver function and nutrition status.
Alkaline phosphataseIncl.
Liver, bile duct and bone conditions.
ALT (SGPT)Incl.
Liver cell damage; the most common liver screening test.
AST (SGOT)Incl.
Liver cell damage.
Direct bilirubinIncl.
Bile duct obstruction.
Gamma-GTIncl.
Bile duct and alcohol-related liver stress.
Globulin and A/G ratioIncl.
Immune protein levels.
Total bilirubinIncl.
Jaundice, liver and bile problems.
Total proteinIncl.
Nutrition and liver/kidney protein handling.
Kidney & Electrolytes
Estimated GFRIncl.
Kidney filtering capacity; stages chronic kidney disease.
Uric acidIncl.
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolIncl.
Protective cholesterol level.
LDL cholesterolIncl.
The main cholesterol driving heart disease risk.
Total cholesterolIncl.
Cardiovascular risk.
TriglyceridesIncl.
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucoseIncl.
Diabetes and prediabetes.
Hemoglobin A1cIncl.
Average blood sugar over the past three months; diabetes.
Tumor Markers
AFPIncl.
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CA-125Incl.
Ovarian cancer marker.
CA 19-9Incl.
Pancreatic and biliary cancer marker.
CEAIncl.
Colorectal and other GI cancer marker.
EBV VCA-IgAIncl.
Nasopharyngeal cancer risk (common in Taiwan and southern China).
Urine & Stool
Stool occult blood (FIT)Incl.
Colorectal cancer and polyps; the standard non-invasive colon screen.
Cardiac
Arterial stiffness (ABI / PWV)Incl.
Peripheral artery disease and arterial stiffness.
Resting ECGIncl.
Heart rhythm and signs of prior heart damage.
X-ray
Chest X-rayIncl.
Lung, heart size and chest abnormalities.
Ultrasound
Abdominal ultrasoundIncl.
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundAdd-on
Breast lumps; complements mammography, especially in dense breasts.
Carotid ultrasoundIncl.
Plaque in the neck arteries; stroke risk.
Pelvic (gynecologic) ultrasoundAdd-on
Uterus and ovary abnormalities (fibroids, cysts).
Prostate ultrasoundAdd-on
Prostate size and abnormalities.
Thyroid ultrasoundAdd-on
Thyroid nodules.
CT Imaging
Coronary artery calcium scoreIncl.
Calcified plaque in heart arteries; refines heart attack risk.
Low-dose chest CTIncl.
Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
MRI Imaging
Brain MR angiographyIncl.
Aneurysms and narrowed brain arteries.
Eye
Color visionIncl.
Color vision deficiency.
Intraocular pressureIncl.
Glaucoma.
Visual acuityIncl.
Vision sharpness.
ENT & Dental
Hearing testIncl.
Hearing loss.
Also listed: Albumin/globulin ratio (A/G), BUN (blood urea nitrogen), Body water percentage, Chest circumference, Creatinine (CRE), Ideal body weight, Internal medicine physical exam and physician summary, Prostate cancer marker (PSA), Urinalysis with microscopic examination (18 items).

Before you book

If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
Pojen General Hospital
District hospital
Taipei · Songshan

About 7 minutes' walk (558 m) from Taipei Arena station

On the OCAC i僑卡 partner list. Card holders can ask the center about a discount.

15 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Before and on the day
  • For patients with a sit-down toilet, the center advises turning to sit facing backward or sitting as far forward as possible, lining the bowl with tissue before passing stool, then using the sampling stick to collect a peanut-sized piece of stool that has not touched water into the specimen box.

    Source ↗ · checked 2026-09-26

  • Before the chest X-ray, patients are asked to remove their bra.

    Source ↗ · checked 2026-09-26

  • Patients who are pregnant, planning pregnancy, or unsure whether they are pregnant are asked to defer radiological and invasive exams.

    Source ↗ · checked 2026-09-26

  • The center asks patients to try to avoid scheduling the checkup during menstruation.

    Source ↗ · checked 2026-09-26

  • For patients having a Pap smear or cervical high-risk screening, the day before the exam they are asked to avoid vaginal douching, vaginal suppositories, and sexual intercourse.

    Source ↗ · checked 2026-09-26

  • Patients without prior sexual experience are advised against internal exams such as a Pap smear or cervical-cancer high-risk screening.

    Source ↗ · checked 2026-09-26

  • Patients who take medication regularly are asked to avoid taking it on the morning of the checkup, bring the medication along, and take it after finishing the fasting parts of the exam.

    Source ↗ · checked 2026-09-26

  • Diabetic patients are asked to take their medication according to its instructions, either with or after a meal.

    Source ↗ · checked 2026-09-26

Ask your own doctor before changing any medicine.

Results
  • The physician reviews and summarizes each patient's exam results on the same day as part of the checkup.

    Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$2,615–3,705 for a woman (41 of 42 tests) and US$2,581–3,671 for a man (40 of 41 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 3.3 mSv from the tests we could identify, a typical adult dose for these exams: roughly 1.1 years of natural background radiation (about 3 mSv a year, US average).

This package also lists 9 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Chest X-ray · about 0.1 mSv
  • Coronary artery calcium score · about 1.7 mSv
  • Low-dose chest CT · about 1.5 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 20 of these tests
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding the ankle-brachial index to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement that is limited to coronary artery calcium scoring; its September 2024 research plan excludes the ABI, which it says will be evaluated as a screening test in a separate future topic on peripheral artery disease.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for peripheral artery disease and cardiovascular disease risk with the ankle-brachial index in asymptomatic adults. (2018) · USPSTF ↗ Note: A separate statement from the nontraditional-risk-factor one; see the other abi_pwv row. Neither USPSTF statement mapped here addresses pulse wave velocity (arterial stiffness).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with the CA-125 blood test. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers CA-125 and transvaginal/pelvic ultrasound; see pelvic_ultrasound.
Recommended against (grade D)The USPSTF recommends against screening for pancreatic cancer in asymptomatic average-risk adults. (2019) · USPSTF ↗ Note: The recommendation states there are currently no accurate, validated biomarkers for early detection of pancreatic cancer and that the USPSTF does not recommend screening the general population by any method; it does not name CA 19-9. The D grade applies to screening this population by any method, not to CA 19-9 as a separately graded test. It does not apply to people at high risk because of an inherited genetic syndrome or familial pancreatic cancer.
Recommended against (grade D)The USPSTF recommends against screening for asymptomatic carotid artery stenosis in the general adult population. (2021) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding a coronary artery calcium score to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018; an update is in progress) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF has an update in progress specifically on coronary artery calcium scoring for enhanced cardiovascular risk assessment; the 2018 I statement remains the current final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in adults aged 45 to 49 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended (grade A/B)The USPSTF recommends screening for colorectal cancer in all adults aged 50 to 75 years, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT). (2021) · USPSTF ↗ Note: Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Selective (grade C)The USPSTF recommends that clinicians selectively offer colorectal cancer screening, including with an annual stool test for occult blood (FIT or high-sensitivity gFOBT), to adults aged 76 to 85 years based on overall health, prior screening history and the patient's preferences. (2021) · USPSTF ↗ Note: Grade C reflects an individual decision rather than a blanket recommendation for or against. Applies to asymptomatic adults at average risk of colorectal cancer: no prior colorectal cancer, adenomatous polyps or inflammatory bowel disease, and no personal diagnosis or family history of a known genetic disorder that carries a high lifetime risk, such as Lynch syndrome or familial adenomatous polyposis.
Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
General preparation notes for 13 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Stool occult blood (FIT)

Guaiac-based kits usually ask you to avoid red meat, NSAIDs and more than 250mg of vitamin C for a few days beforehand; FIT kits usually need no diet change.

Mention when booking: Tell the center which kit you were given, and ask the prescribing doctor before stopping aspirin taken for the heart.

Chest X-ray

Usually needs no fasting; you remove jewelry, metal objects and sometimes clothing above the waist for a hospital gown.

Mention when booking: Tell the center if you are, or might be, pregnant.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Prostate ultrasound

Usually needs little or no preparation; an enema and antibiotics are mainly for a planned biopsy. A scan through the lower belly instead may need a full bladder.

Mention when booking: Mention aspirin or other blood thinners; if a biopsy is planned, the center may ask about pausing them, so ask the prescribing doctor before changing any medicine.

Coronary artery calcium score

Usually needs about 4 hours without food, caffeine or smoking beforehand; no contrast injection is used for this scan.

Mention when booking: Tell the center if pregnancy is possible.

Afterwards: No recovery time is needed; normal activities can usually resume right away.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

Brain MR angiography

Guidelines on eating and drinking vary by center, so ask when booking. Remove jewelry and metal before the scan.

Mention when booking: Mention a pacemaker, aneurysm clip, cochlear implant or other implanted device, metal fragments, pregnancy, kidney disease, or claustrophobia.

Afterwards: If you take a sedative for claustrophobia or anxiety, you'll need someone to take you home; arrange this before the scan.

Hearing test

Usually needs no special preparation; expect to listen for tones or words through headphones, and sometimes a small probe checks how the eardrum moves.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Prestige Class Health Checkup
US$685
Book this checkup

If this isn't quite right

Other packages at Pojen General Hospital

All packages at Pojen General Hospital →

Similar packages in Taipei

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · Heart and blood vessels · All checkups in Taipei · What a checkup costs in Taiwan